MedTrace Logo

Radiotherapy of Tongue Cancer Using an Intraoral Stent

NCT04337853 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-11-03

No results posted yet for this study

Summary

Radiotherapy of tongue cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The aim of the present study is to confirm that an intraoral stent will give lower dose to the palate throughout the treatment period.

Conditions

  • Tongue Cancer

Interventions

DEVICE

Intraoral stent

Radiotherapy with intraoral stent

OTHER

No intraoral stent

Radiotherapy without intraoral stent

Sponsors & Collaborators

  • Oslo Metropolitan University

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Einar Dale, MD PhD · Oslo University Hospital, Department of Oncology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2018-12-04
Completion
2018-12-04

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04337853 on ClinicalTrials.gov